Evaluation of ceftolozane-tazobactam susceptibility on a French nationwide collection of Enterobacterales

Autor: Agnès B. Jousset, Sandrine Bernabeu, Cécile Emeraud, Rémy A. Bonnin, Alexandra Lomont, Jean Ralph Zahar, Audrey Merens, Christophe Isnard, Nathalie Soismier, Eric Farfour, Vincent Fihman, Nicolas Yin, Olivier Barraud, Hervé Jacquier, Anne-Gaëlle Ranc, Frédéric Laurent, Stéphane Corvec, Louise Ruffier d'Epenoux, Emmanuelle Bille, Nicolas Degand, Chloé Plouzeau, Thomas Guillard, Vincent Cattoir, Asaf Mizrahi, Antoine Grillon, Frédéric Janvier, Cécile Le Brun, Marlène Amara, Mathilda Bastide, Alban Lemonnier, Laurent Dortet

Publikováno v: Journal of Global Antimicrobial Resistance
Journal of Global Antimicrobial Resistance, 2023, 32, pp.78-84. ⟨10.1016/j.jgar.2023.01.003⟩

International audience; Objectives: Ceftolozane-tazobactam (C/T) proved its efficacy for the treatment of infections caused by non-carbapenemase producing Pseudomonas aeruginosa and Enterobacterales. Here, we aimed to provide susceptibility data on l

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecd126d3d9f893524ff4e564b1b4de70
https://www.hal.inserm.fr/inserm-03962400/document

Comparison of 8 versus 15 days of antibiotic therapy for Pseudomonas aeruginosa ventilator-associated pneumonia in adults: a randomized, controlled, open-label trial

Autor: Adrien, Bouglé, Sophie, Tuffet, Laura, Federici, Marc, Leone, Antoine, Monsel, Thomas, Dessalle, Julien, Amour, Claire, Dahyot-Fizelier, François, Barbier, Charles-Edouard, Luyt, Olivier, Langeron, Bernard, Cholley, Julien, Pottecher, Tarik, Hissem, Jean-Yves, Lefrant, Benoit, Veber, Matthieu, Legrand, Alexandre, Demoule, Pierre, Kalfon, Jean-Michel, Constantin, Alexandra, Rousseau, Tabassome, Simon, Arnaud, Foucrier, Nora, Soussi

Publikováno v: Intensive Care Medicine
Intensive Care Medicine, 2022, 48 (7), pp.841-849. ⟨10.1007/s00134-022-06690-5⟩

International audience; Purpose: Duration of antibiotic therapy for ventilator-associated pneumonia (VAP) due to non-fermenting Gram-negative bacilli (NF-GNB), including Pseudomonas aeruginosa (PA) remains uncertain. We aimed to assess the non-inferi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c7ccc4f208ddc6e58a84d54f3cb86f1
https://doi.org/10.1007/s00134-022-06690-5

Aspergillus-Pseudomonas interaction, relevant to competition in airways

Autor: Paolo Visca, Gabriele Sass, Karl V. Clemons, Shajia R Ansari, John C. Penner, Eric Déziel, David A. Stevens, Hasan Nazik, Hemi Shah, Hubertus Haas, Anna-Maria Dietl, Marie-Christine Groleau

Publikováno v: Medical Mycology
Medical Mycology, Oxford University Press, 2019, 57 (Supplement_2), pp.S228-S232. ⟨10.1093/mmy/myy087⟩

International audience; In airways of immunocompromised patients and individuals with cystic fibrosis, Pseudomonas aeruginosa and Aspergillus fumigatus are the most common opportunistic bacterial and fungal pathogens. Both pathogens form biofilms and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc231b5c401cfffd45ab71bfb0765b56
https://doi.org/10.1093/mmy/myy087

Self-association of MreC as a regulatory signal in bacterial cell wall elongation

Autor: Carlos Contreras-Martel, Leandro F. Estrozi, Daniel M. Trindade, Mayara M. Miyachiro, Fernanda Rodrigues-Costa, Ina Attrée, Guy Schoehn, Caíque C. Malospirito, Alexandre Martins, Viviana Job, Andréa Dessen, Lionel Imbert, Manon Janet-Maitre

Publikováno v: Nature Communications
Nature Communications, Nature Publishing Group, 2021, 12 (1), ⟨10.1038/s41467-021-22957-9⟩
Nature Communications, Nature Publishing Group, 2021, 12 (1), pp.2987. ⟨10.1038/s41467-021-22957-9⟩
Nature Communications, Vol 12, Iss 1, Pp 1-10 (2021)
Nature Communications, 2021, 12 (1), pp.2987. ⟨10.1038/s41467-021-22957-9⟩

The elongasome, or Rod system, is a protein complex that controls cell wall formation in rod-shaped bacteria. MreC is a membrane-associated elongasome component that co-localizes with the cytoskeletal element MreB and regulates the activity of cell w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10cfc0966af3321d6631a2a3d7bddc79
http://europepmc.org/articles/PMC8137920

Characterization of VIM-4 Producing Clinical Pseudomonas aeruginosa Isolates from Western Algeria: Sequence Type and Class 1 Integron Description

Autor: Manon Lounes, Salim Aberkane, Olivier Barraud, Radia Dali-Yahia, Sylvain Godreuil, Helen Jean Pierre, Abdelaziz Touati, Karima Zenati, Leila Yazi, Fatma Zohra Zaidi

Publikováno v: Microbial Drug Resistance
Microbial Drug Resistance, Mary Ann Liebert, 2020, 26 (12), pp.1437-1441. ⟨10.1089/mdr.2019.0225⟩

International audience; Objectives: Pseudomonas aeruginosa occupies a central position in nosocomial infections and remains a significant cause of morbidity and mortality. The aim of this study was to characterize carbapenem resistance mechanisms in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42b19738b194c408452375fee7a6dbcb
https://hal.umontpellier.fr/hal-03384635